當前位置:深圳遠揚化學技術有限公司>>技術文章>>英國NIBSC標準品WHO標準品應用
英國NIBSC標準品WHO標準品是深圳遠揚化學技術有限公司的熱銷產品,主要應用在哪些領域呢?
英國國家生物制品檢定所是WHO的一個標準品供應中心實驗室,它的核心工作是制備、保存和分發WHO用于檢測生物制品質量的標準品。NIBSC制備的流感毒株和檢測抗原、抗血清標準品,保障了各廠家順利的研究和生產。NIBSC提供對投入英國市場的生物藥品的獨立測試,尤其是用于英國兒童免疫計劃的疫苗;它同時也是歐盟控制藥品進入歐盟市場的藥品控制實驗室(OMCL)。 如果出現不能滿足藥品存放要求或患者出現不良反應等問題,NIBSC 也可對已投入歐盟市場的產品進行檢驗。
NIBSC 戰略目標:對有關生物產品的問題給出回復和建議;提供生物藥品方面的國家科技力量,維持滿足科學和藥物學領域新發展需求的靈活性、專業知識和設施;
作為化驗方法(如量化生物學活性以及確定生物產品特征和進行安全評估)方面的機構運營并得到認同;
在歐洲生物產品的控制和標準化方面,繼續發揮科學基礎開發的中心作用;
在生物藥品法規的科學方面幫助社會達成共識,并籍于此,與世界衛生組織緊密合作;
在控制和標準化的關鍵領域實現和維護質量鑒定。
生物藥品控制
藥品中使用的生物物質包括病毒和細菌疫苗、從人類血液提取的產物、荷爾蒙以及其它諸如細胞分裂素和生長素等治療藥物。
這些生物物質對藥物學和公眾健康做出了巨大貢獻并發揮著越來越大的作用,它們大大改善了*的疾病預防、診斷和治療。
深圳遠揚化學技術有限公司所售英國NIBSC標準品部分產品列表:
(篇幅有限,更多產品,歡迎進入我司展臺查詢)
07/288 | BCG Vaccine of Russian BCG-I sub-strain(15st WHO Reference Reagent) |
01/535 | Meningococcal serogroup W polysaccharide |
07/352 | BCG Vaccine of Russian BCG-I sub-strain(79st WHO Reference Reagent) |
07/281 | BCG Vaccine of Russian BCG-I sub-strain(8st WHO Reference Reagent) |
10/164 | Reteplase Reference Material |
95/571 | Interleukin-32 (Human, rDNA derived) |
13/219 | Influenza Antigen B/Massachusetts/02/2097 (Egg derived) |
10/149 | Reteplase Reference Material |
07/344 | BCG Vaccine of Russian BCG-I sub-strain(71st WHO Reference Reagent) |
01/484 | Meningococcal serogroup W polysaccharide |
13/154 | Influenza Antigen B/Massachusetts/02/2032 (Egg derived) |
13/151 | Influenza Antigen B/Massachusetts/02/2029 (Egg derived) |
10/143 | Reteplase Reference Material |
01/476 | Meningococcal serogroup W polysaccharide |
12/B623-057 | QCRFLUAH1N1QC1-Influenza AH1N1 QC55 |
12/B623-053 | QCRFLUAH1N1QC1-Influenza AH1N1 QC51 |
12/B623-051 | QCRFLUAH1N1QC1-Influenza AH1N1 QC49 |
13/275 | Polio Anti Sabin type 58 (inactivated) Serum |
12/B623-003 | QCRFLUAH1N1QC1-Influenza AH1N1 QC1 |
07/315 | BCG Vaccine of Russian BCG-I sub-strain(42st WHO Reference Reagent) |
13/285 | Polio Anti Sabin type 68 (inactivated) Serum |
03/104-019 | HTLV-4 (antibody) Monitor Sample |
13/153 | Influenza Antigen B/Massachusetts/02/2031 (Egg derived) |
12/B623-097 | QCRFLUAH1N1QC1-Influenza AH1N1 QC95 |
10/144 | Reteplase Reference Material |
95/657 | Interleukin-118 (Human, rDNA derived) |
13/219 | Polio Anti Sabin type 2 (inactivated) Serum |
03/104-085 | HTLV-70 (antibody) Monitor Sample |
01/472 | Meningococcal serogroup W polysaccharide |
13/146 | Influenza Antigen B/Massachusetts/02/2024 (Egg derived) |
07/329 | BCG Vaccine of Russian BCG-I sub-strain(56st WHO Reference Reagent) |
13/165 | Influenza Antigen B/Massachusetts/02/2043 (Egg derived) |
13/281 | Polio Anti Sabin type 64 (inactivated) Serum |
07/306 | BCG Vaccine of Russian BCG-I sub-strain(33st WHO Reference Reagent) |
03/104-110 | HTLV-95 (antibody) Monitor Sample |
07/358 | BCG Vaccine of Russian BCG-I sub-strain(85st WHO Reference Reagent) |
01/452 | Meningococcal serogroup W polysaccharide |
13/277 | Polio Anti Sabin type 60 (inactivated) Serum |
07/287 | BCG Vaccine of Russian BCG-I sub-strain(14st WHO Reference Reagent) |
13/287 | Polio Anti Sabin type 70 (inactivated) Serum |
13/307 | Polio Anti Sabin type 90 (inactivated) Serum |
10/186 | Reteplase Reference Material |
10/133 | Reteplase Reference Material |
03/104-094 | HTLV-79 (antibody) Monitor Sample |
12/B623-031 | QCRFLUAH1N1QC1-Influenza AH1N1 QC29 |
07/377 | BCG Vaccine of Russian BCG-I sub-strain(104st WHO Reference Reagent) |
13/269 | Polio Anti Sabin type 52 (inactivated) Serum |
10/179 | Reteplase Reference Material |
10/210 | Reteplase Reference Material |
13/266 | Polio Anti Sabin type 49 (inactivated) Serum |
07/295 | BCG Vaccine of Russian BCG-I sub-strain(22st WHO Reference Reagent) |
07/371 | BCG Vaccine of Russian BCG-I sub-strain(98st WHO Reference Reagent) |
12/B623-078 | QCRFLUAH1N1QC1-Influenza AH1N1 QC76 |
01/462 | Meningococcal serogroup W polysaccharide |
95/591 | Interleukin-52 (Human, rDNA derived) |
01/464 | Meningococcal serogroup W polysaccharide |
10/159 | Reteplase Reference Material |
03/104-046 | HTLV-31 (antibody) Monitor Sample |
13/213 | C-Peptide, Human. 68st International Standard. |
13/222 | Influenza Antigen B/Massachusetts/02/2100 (Egg derived) |
07/373 | BCG Vaccine of Russian BCG-I sub-strain(100st WHO Reference Reagent) |
12/B623-110 | QCRFLUAH1N1QC1-Influenza AH1N1 QC108 |
13/196 | C-Peptide, Human. 51st International Standard. |
12/B623-043 | QCRFLUAH1N1QC1-Influenza AH1N1 QC41 |
01/494 | Meningococcal serogroup W polysaccharide |
13/192 | Influenza Antigen B/Massachusetts/02/2070 (Egg derived) |
07/325 | BCG Vaccine of Russian BCG-I sub-strain(52st WHO Reference Reagent) |
07/348 | BCG Vaccine of Russian BCG-I sub-strain(75st WHO Reference Reagent) |
13/223 | Influenza Antigen B/Massachusetts/02/2101 (Egg derived) |
12/B623-086 | QCRFLUAH1N1QC1-Influenza AH1N1 QC84 |
13/191 | Influenza Antigen B/Massachusetts/02/2069 (Egg derived) |
01/488 | Meningococcal serogroup W polysaccharide |
07/343 | BCG Vaccine of Russian BCG-I sub-strain(70st WHO Reference Reagent) |
12/B623-019 | QCRFLUAH1N1QC1-Influenza AH1N1 QC17 |
10/125 | Reteplase Reference Material |
10/155 | Reteplase Reference Material |
13/185 | Influenza Antigen B/Massachusetts/02/2063 (Egg derived) |
13/243 | C-Peptide, Human. 98st International Standard. |
13/137 | Influenza Antigen B/Massachusetts/02/2015 (Egg derived) |
13/201 | C-Peptide, Human. 56st International Standard. |
07/311 | BCG Vaccine of Russian BCG-I sub-strain(38st WHO Reference Reagent) |
13/242 | C-Peptide, Human. 97st International Standard. |
13/175 | C-Peptide, Human. 30st International Standard. |
13/201 | Influenza Antigen B/Massachusetts/02/2079 (Egg derived) |
03/104-041 | HTLV-26 (antibody) Monitor Sample |
03/104-074 | HTLV-59 (antibody) Monitor Sample |
95/646 | Interleukin-107 (Human, rDNA derived) |
13/156 | C-Peptide, Human. 11st International Standard. |
01/465 | Meningococcal serogroup W polysaccharide |
03/104-050 | HTLV-35 (antibody) Monitor Sample |
10/121 | Reteplase Reference Material |
13/235 | Influenza Antigen B/Massachusetts/02/2113 (Egg derived) |
01/519 | Meningococcal serogroup W polysaccharide |
07/364 | BCG Vaccine of Russian BCG-I sub-strain(91st WHO Reference Reagent) |
95/566 | Interleukin-27 (Human, rDNA derived) |
13/204 | C-Peptide, Human. 59st International Standard. |
13/205 | Influenza Antigen B/Massachusetts/02/2083 (Egg derived) |
13/241 | C-Peptide, Human. 96st International Standard. |
07/324 | BCG Vaccine of Russian BCG-I sub-strain(51st WHO Reference Reagent) |
95/626 | Interleukin-87 (Human, rDNA derived) |
請輸入賬號
請輸入密碼
請輸驗證碼
以上信息由企業自行提供,信息內容的真實性、準確性和合法性由相關企業負責,化工儀器網對此不承擔任何保證責任。
溫馨提示:為規避購買風險,建議您在購買產品前務必確認供應商資質及產品質量。